In Ayurveda, turmeric is often called liquid gold of Ayurveda because of its healing power and nutritional benefits. It is ...
Living with chronic pain can feel overwhelming, especially when conventional treatments fall short. You've probably heard ...
(RTTNews) - Omeros Corp. (OMER), a clinical-stage biopharmaceutical company focused on complement-mediated diseases, oncology, and addictive disorders, today announced its financial results for the ...
In the bovine dairy sector, the pursuit of rapid genetic advancement has prompted the adoption of increasingly younger parental figures for both males and females. While physiological limitations and ...
Authors: Wangjie Li, Xingjia Xie, Yishuang Li, Wenhao Guan, Kaidi Wang, Pengyu Ren, Lin Li, Qingyang Hong Subjects: Subjects: Sound (cs.SD); Audio and Speech ...
Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitor (single agonists such as semaglutide) and also dual glucose-dependent ...
InMed’s INM-901 Demonstrates Potential as a Multi-factorial Approach to Treating Alzheimer’s Disease
InMed Pharmaceuticals (Nasdaq:INM) recently released preclinical data indicating its proprietary, small molecule compound, INM-901, targets multiple biological pathways associated with Alzheimer’s ...
Coronary artery disease (CAD) is the major cause of death in patients with type 2 diabetes mellitus. Although demographic and clinical factors associated with extent of CAD in patients with diabetes ...
InMed Pharmaceuticals is making strides in Alzheimer’s research with its development of a cannabinoid-based compound that aims to protect and rejuvenate brain neurons. During Benzinga’s virtual event ...
Bruno R. Bastos, MD, discusses findings from a study which assessed the pharmacodynamic and radiographic changes among patients with renal cell carcinoma who were treated with the combination of ...
Bruno R. Bastos, MD, discusses the future following a study assessing the changes among patients with renal cell carcinoma who were treated with nivolumab and TPST-1120. Bruno R. Bastos, MD, discusses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results